Posted in | News | Mining Business

Court Approves Business Combination of Eagle Hill, Oban, Ryan and Corona

Eagle Hill Exploration Corporation, Oban Mining Corporation, Ryan Gold Corp. and Corona Gold Corporation are pleased to announce that Eagle Hill, Ryan and Corona have been granted final court approval from the Ontario Superior Court of Justice (Commercial List) in connection with the proposed business combination pursuant to which Oban will acquire all of the common shares of each of Eagle Hill, Ryan and Corona by way of a court approved plan of arrangement.

As announced by the Parties on August 20, 2015, all requisite shareholder approvals of the Arrangement were received at the special meetings of shareholders of each of the Parties, all of which were held on August 20, 2015. The continuance of Eagle Hill from British Columbia to Ontario also received the required shareholder approval, and was effected on August 20, 2015.

The Arrangement and the concurrent private placement of common shares of Oban to Osisko (the "Osisko Private Placement") are expected to close on or about August 25, 2015. The Arrangement is subject to, among other things, receiving the requisite stock exchange approvals and to the satisfaction of other customary conditions for a transaction of this nature. It is also expected that the consolidation of the common shares of Oban on the basis of one post-consolidation common share for each 20 pre-consolidation common shares (the "Consolidation") shall be effected following the effective time of the Arrangement on the date of closing of the Arrangement.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.